Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients

NCT05788341 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT05788341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients
Lead sponsor
Rabin Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 30, 2023
Completion date
April 30, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes